Search Results - "Salmen, A"

Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature by Diem, L., Hoepner, R., Bagnoud, M., Salmen, A., Chan, A., Friedli, C.

“…To describe frequency of natalizumab related eosinophilia and clinical symptoms of eosinophilic disease in our monocentric cohort. Comparison of clinical…”
Get full text

Rapid differentiation of MOGAD and MS after a single optic neuritis by Pakeerathan, T., Havla, J., Schwake, C., Salmen, A., Ringelstein, M., Aktas, O., Weise, M., Gernert, J. A., Kornek, B., Bsteh, G., Pröbstel, A.-K., Papadopoulou, A., Kulsvehagen, L., Ayroza Galvão Ribeiro Gomes, A. B., Cerdá-Fuertes, N., Oertel, F. C., Duchow, A. S., Paul, F., Stellmann, J. P., Stolowy, N., Hellwig, K., Schneider-Gold, C., Kümpfel, T., Gold, R., Albrecht, P., Ayzenberg, I.

“…Background Optic neuritis (ON) is a common manifestation of multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein IgG-associated disease (MOGAD)…”
Get full text

Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode by Pakeerathan, T., Havla, J., Schwake, C., Salmen, A., Bigi, S., Abegg, M., Brügger, D., Ferrazzini, T., Runge, A.-K., Breu, M., Kornek, B., Bsteh, G., Felipe-Rucián, A., Ringelstein, M., Aktas, O., Karenfort, M., Wendel, E., Kleiter, I., Hellwig, K., Kümpfel, T., Thiels, C., Lücke, T., Gold, R., Rostasy, K., Ayzenberg, I.

“…Background Optic neuritis (ON) is the most prevalent manifestation of pediatric multiple sclerosis (MS ped ) and myelin-oligodendrocyte glycoprotein…”
Get full text

Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers by Diem, L, Ovchinnikov, A, Friedli, C, Hammer, H, Kamber, N, Chan, A, Salmen, A, Findling, O, Hoepner, R

“…•High efficacy of OCR in patients with RMS.•Tolerability of OCR was in general good.•Infection rates highlight the need for pharmacovigilance for OCR…”
Get full text

Management of disease‐modifying treatments in neurological autoimmune diseases of the central nervous system by Salmen, A., Gold, R., Chan, A.

“…Summary The therapeutic armamentarium for autoimmune diseases of the central nervous system, specifically multiple sclerosis and neuromyelitis optica, is…”
Get full text

Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS) by Hammer, H, Kamber, N, Pistor, M, Diem, L, Friedli, C, Chan, A, Hoepner, R, Salmen, A

“…Neutropenia is a rare complication of anti-CD20 treatment, such as Ocrelizumab (OCR) in Multiple Sclerosis (MS). Using FDA´s Adverse Event Reporting System…”
Get full text

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction by Recke, A., Oei, A., Hübner, F., Fechner, K., Graf, J., Hagenah, J., May, C., Woitalla, D., Salmen, A., Zillikens, D., Gold, R., Schlumberger, W., Schmidt, E.

Get full text

German guideline for diagnosis and treatment of multiple sclerosis – a survey focusing neurologists in daily practise by Heesen, C., Mokry, C., Salmen, A., Hegen, H., Mäurer, M., Warnke, C., Gehring, K., Berthele, A., Meier, U.

“…We performed a web-based survey among German-speaking neurologists to evaluate the acceptance of the 2021 German guideline in the diagnosis and treatment of…”
Get full text

Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study by Kamm, Christian Philipp, Barin, L., Gobbi, C., Pot, C., Calabrese, P., Salmen, A., Achtnichts, L., Kesselring, J., Puhan, M. A., von Wyl, V.

“…Background Patient satisfaction is predictive of adherence, malpractice litigation and doctor-switching. Objective To investigate which factors of the first…”
Get full text

Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? by Diem, L., Evangelopoulos, M.E., Karathanassis, D., Natsis, V., Kamber, N., Hammer, H., Friedli, C., Chan, A., Helbling, A., Penner, I.K., Salmen, A., Walther, S., Stegmayer, K., Hoepner, R.

“…Fatigue is one of the most disabling and difficult to treat symptoms of autoimmune diseases and frequently presents in people with multiple sclerosis (PwMS)…”
Get full text

Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis by Mokry, C, Warnke, C, Gehring, K, Hegen, H, Salmen, A, Kraemer, M, Kleiter, I, Fasshauer, E, Scheiderbauer, J, Lühmann, D, Köpke, S, Berthele, A, Heesen, C

“…•first implementation study of a clinical practice guideline in MS.•early aggressive treatment and treatment stop as major areas of controversy.•overall…”
Get full text

New therapeutic options in multiple sclerosis by Salmen, A, Chan, A

“…Therapeutic options in the treatment of multiple sclerosis (MS) have broadened notably over the past years, especially for relapsing-remitting forms of MS. The…”
Get more information

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS by Schrewe, L, Lill, C M, Liu, T, Salmen, A, Gerdes, L A, Guillot-Noel, L, Akkad, D A, Blaschke, P, Graetz, C, Hoffjan, S, Kroner, A, Demir, S, Böhme, A, Rieckmann, P, ElAli, A, Hagemann, N, Hermann, D M, Cournu-Rebeix, I, Zipp, F, Kümpfel, T, Buttmann, M, Zettl, U K, Fontaine, B, Bertram, L, Gold, R, Chan, A

“…Despite pleiotropic immunomodulatory effects of apolipoprotein E (apoE) in vitro, its effects on the clinical course of experimental autoimmune…”
Get full text

Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action by Klotz, L, Berthele, A, Brück, W, Chan, A, Flachenecker, P, Gold, R, Haghikia, A, Hellwig, K, Hemmer, B, Hohlfeld, R, Korn, T, Kümpfel, T, Lang, M, Limmroth, V, Linker, R A, Meier, U, Meuth, S G, Paul, F, Salmen, A, Stangel, M, Tackenberg, B, Tumani, H, Warnke, C, Weber, M S, Ziemssen, T, Zipp, F, Wiendl, H

“…With the approval of various substances for the immunotherapy of multiple sclerosis (MS), treatment possibilities have improved significantly over the last few…”
Get full text

Sensitive and Specific Method for Rapid Identification of Streptococcus pneumoniae Using Real-Time Fluorescence PCR by MCAVIN, James C, REILLY, Patricia A, NIEMEYER, Debra, LOHMAN, Kenton L, ROUDABUSH, Robert M, BARNES, William J, SALMEN, Ann, JACKSON, Glen W, BENINGA, Kathleen K, ASTORGA, Alicia, MCCLESKEY, Ferne K, HUFF, William B

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy by Salmen, A., von Ahsen, N., Trampe, A.K., Hoepner, R., Plavina, T., Subramanyam, M., Kuesters, G., Gold, R., Chan, A.

“…Risk assessment for natalizumab-associated progressive multifocal leukoencephalopathy (Nat-PML) comprises the anti-JC virus (JCV) antibody index (AI). The…”
Get full text

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study by Benkert, Pascal, Meier, Stephanie, Schaedelin, Sabine, Manouchehrinia, Ali, Yaldizli, Özgür, Maceski, Aleksandra, Oechtering, Johanna, Achtnichts, Lutz, Conen, David, Derfuss, Tobias, Lalive, Patrice H, Mueller, Christian, Müller, Stefanie, Naegelin, Yvonne, Oksenberg, Jorge R, Pot, Caroline, Salmen, Anke, Willemse, Eline, Kockum, Ingrid, Blennow, Kaj, Zetterberg, Henrik, Gobbi, Claudio, Kappos, Ludwig, Wiendl, Heinz, Berger, Klaus, Sormani, Maria Pia, Granziera, Cristina, Piehl, Fredrik, Leppert, David, Kuhle, Jens, Aeschbacher, Stefanie, Barakovic, Muhamed, Buser, Andreas, Chan, Andrew, Disanto, Giulio, D'Souza, Marcus, Du Pasquier, Renaud, Findling, Oliver, Galbusera, Riccardo, Hrusovsky, Kevin, Khalil, Michael, Lorscheider, Johannes, Mathias, Amandine, Orleth, Annette, Radue, Ernst-Wilhelm, Rahmanzadeh, Reza, Sinnecker, Tim, Subramaniam, Suvitha, Vehoff, Jochen, Wellmann, Sven, Wuerfel, Jens, Zecca, Chiara

“…Serum neurofilament light chain (sNfL) is a biomarker of neuronal damage that is used not only to monitor disease activity and response to drugs and to…”
Get full text

A PCR assay for identification of Enterococcus faecium by CHENG, S, MCCLESKEY, F. K, GRESS, M. J, PETROZIELLO, J. M, LIU, R, NAMDARI, H, BENINGA, K, SALMEN, A, DELVECCHIO, V. G

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis by Meier, Stephanie, Willemse, Eline A J, Schaedelin, Sabine, Oechtering, Johanna, Lorscheider, Johannes, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Subramaniam, Suvitha, Barro, Christian, Abdelhak, Ahmed, Thebault, Simon, Achtnichts, Lutz, Lalive, Patrice, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, Zecca, Chiara, D'Souza, Marcus, Orleth, Annette, Khalil, Michael, Buchmann, Arabella, Du Pasquier, Renaud, Yaldizli, Özgür, Derfuss, Tobias, Berger, Klaus, Hermesdorf, Marco, Wiendl, Heinz, Piehl, Fredrik, Battaglini, Marco, Fischer, Urs, Kappos, Ludwig, Gobbi, Claudio, Granziera, Cristina, Bridel, Claire, Leppert, David, Maleska Maceski, Aleksandra, Benkert, Pascal, Kuhle, Jens

“…There is a lack of validated biomarkers for disability progression independent of relapse activity (PIRA) in multiple sclerosis (MS). To determine how serum…”
Get more information

Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression (P5-3.016) by Meier, Stephanie, Benkert, Pascal, Maceski, Aleksandra Maleska, Schaedelin, Sabine, Oechtering, Johanna, Melie-Garcia, Lester, Cagol, Alessandro, Barakovic, Muhamed, Galbusera, Riccardo, Achtnichts, Lutz, Lalive, Patrice H., Bridel, Claire, Müller, Stefanie, Pot, Caroline, Salmen, Anke, Disanto, Giulio, Zecca, Chiara, Abdelhak, Ahmed, Barro, Christian, Thebault, Simon, D’Souza, Marcus, Derfuss, Tobias, Orleth, Annette, Khalil, Michael, Yaldizli, Özguer, Hermesdorf, Marco, Wiendl, Heinz, Piehl, Fredrik, Fischer, Urs, Kappos, Ludwig, Gobbi, Claudio, Granziera, Cristina, Leppert, David, Willemse, Eline A.J., Kuhle, Jens

“…Abstract only…”
Get full text